The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
CAPITALSOURCE, INC. | COM | 14055X102 | 10,627 | 1,132,948 | SH | DFND | 1 | 0 | 1,132,948 | 0 | |
GAP, INC. | COM | 364760108 | 178,222 | 4,270,830 | SH | DFND | 1 | 0 | 4,270,830 | 0 | |
IRONWOOD PHARMACEUTICALS INC. | COM Class A | 4633X108 | 1,922 | 193,588 | SH | DFND | 1 | 0 | 193,588 | 0 | |
VANGUARD INTL EQUITY INDEX F | ALLWRLD EX US | 922042775 | 15,533 | 351,260 | SH | DFND | 0 | 351,260 | 0 | ||
VANGUARD INTL EQUITY INDEX F | FTSE EMR MKT ETF | 922042858 | 17,897 | 461,312 | SH | DFND | 0 | 461,312 | 0 |